G. Dissmeyer
FDA investigator
Appears on 1 document from 2019, mostly at sites in China. Most often cites written procedures; deviations (21 CFR 211.100).
- 1
- Documents on file
- 2.0
- Observations per 483
- 2019
- First seen
- 2019
- Most recent
What they cite most
From 2 observations- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.192Production record review1
Activity by year
2019: 1
Where
China 1
Is G. Dissmeyer coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2019-09-20 | 483 Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.Sep 20, 2019 · Taizhou City, China | Taizhou City, China | 2 |
About this profile
What does G. Dissmeyer inspect?
G. Dissmeyer appears on 1 document on file covering 1 site, mostly in China.
What do they cite most often?
21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.192.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for G. Dissmeyer is dated Sep 20, 2019.